VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial.
Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343.
View in:
PubMed
subject areas
Atherosclerosis
Biomarkers
Clinical Decision-Making
Clinical Trials as Topic
Drug Costs
Dyslipidemias
Eicosapentaenoic Acid
Eligibility Determination
Humans
Hypolipidemic Agents
Lipids
Multicenter Studies as Topic
Patient Selection
Risk Factors
Treatment Outcome
United States
United States Department of Veterans Affairs
authors with profiles
CHRISTIE BALLANTYNE
LAURA PETERSEN
SALIM VIRANI
XIAOMING JIA
VIJAY NAMBI